Current trends in β-lactam based β-lactamases inhibitors

Current Medicinal Chemistry

Volumn 18, Issue 27, 2011, Pages 4223-4236

  Biondi, S ^a   Long, S ^b   Panunzio, M ^b   Qin, W L ^b  

^a Innovative Solution   (Italy)

^b CNR   (Italy)

Author keywords

lactamase inhibitors; Antibiotic resistance; BLI; Carbapenemase; Carbapenems; Cephalosporins; Metallo lactamase; Newer lactams; NXL 104; Penicillins; Serine lactamase

Indexed keywords

3 (4 AMINO 1,1 DIMETHYLBUTYL) 6 (1 HYDROXYETHYL)OXAPENEM 3 CARBOXYLIC ACID; 6 (1 METHYL 1,2,3 TRIAZOL 4 YLMETHYLENE)PENEM 3 CARBOXYLIC ACID; AM 114; AM 115; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AVIBACTAM; BAL 30376; BETA LACTAMASE INHIBITOR; BLI 489; CEPHEM DERIVATIVE; CLAVULANIC ACID; IMIPENEM; LK 157; LK 157 E 1; LK 157 E 2; LK 159; LN 1255; PENEM DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RO 481256; SULBACTAM; SULFONE DERIVATIVE; SULPERAZON; SULTAMICILLIN; SYN 2190; TAZOBACTAM; TIMENTIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTEROIDES FRAGILIS; DRUG CLASSIFICATION; DRUG RESEARCH; ESCHERICHIA COLI; GENE OVEREXPRESSION; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; SUICIDAL IDEATION;

ANIMALS; BETA-LACTAMASES; BETA-LACTAMS; ENZYME INHIBITORS; HUMANS; OCTANES;

EID: 80052223781     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797189655     Document Type: Review

References (119)

1. Fleming, A. On the antibacterial action of cultures of Penicillium with special reference to their use in the isolation of B influenza. British J. Exp. Pathol. 1929, 10, 226-239
2. th ed.; McGraw Hill: New York, 1996
3. Jevons, M. P., Celbenin'-resistant Staphylococci. Br. Med. J. 1961, 1, 124-125
4. Hawkey, P. M. Molecular epidemiology of clinically significant antibiotic resistance genes. British J. Pharmacol. 2008, 153, 406S-413S
5. Walsh, T. R.; Toleman, M. A.; Poirel, L.; Nordman, P. Metallo-beta- lactamases: the quiet before the storm? Clin. Microbiol. Rev. 2005, 18, 306-325
6. Livermore, D. M. beta-lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 1995, 8, 557-584
7. Kumarasamy, K. K.; Toleman, M. A.; Walsh, T. R.; Bagaria, J.; Butt, F. a.; Balakrishnan, R.; Chaudhary, U.; Doumith, M.; Giske, C. G.; Irfan, S.; Krishnan, P.; Kumar, A. V.; Maharjan, S.; Mushtaq, S.; Noorie, T.; Paterson, D. L.; Pearson, A.; Perry, C.; Pike, R.; Rao, B.; Ray, U.; Sarma, J. B.; Sharma, M.; Sheridan, E.; Thirunarayan, M. A.; Turton, J.; Upadhyay, S.; Warner, M.; Welfare, W.; Livermore, D. M.; Woodford, N. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. The Lancet Infectious Diseases 2010, 10, 597-602
8. Morin, R. B.; Gorman, M. Chemistry and Biology of β-Lactam Antibiotics. Acad. Press: New York, 1982; Vol. 1.
9. Heritage, J.; M'Zali, F. H.; Gascoyne-Binzi, D.; Hawkey, P. M. Evolution and spread of SHV extended-spectrum beta-lactamases in Gram-negative bacteria. J. Antimicrob. Chemother. 1999, 44, 309-318 (Pubitemid 29425681)
10. Chaibi, E. B.; Sirot, D.; Paul, G.; Labia, R. Inhibitor-resistant TEM betalactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 1999, 43, 447-458 (Pubitemid 29182292)
11. Shahid, M.; Sobia, E.; Singh, A.; Malik, A.; Khan, H. M.; Jonas, D.; Hawkey, P. M. Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive update. Critical Reviews in Microbiology 2009, 35, 81-108
12. Zong, Z. Y.; Lu, X. J.; Gao, Y. Y. Metallo-beta-lactamases of nonfermenting Gram-negative bacteria. Reviews in Medical Microbiology 2003, 14, 79-93
13. Andreotti, D.; Biondi, S.; Di Modugno, E., β-Lactam Antibiotics. In Burger's Medicinal Chemistry, 6th ed.; Abraham, D. J., Ed. Johon Wiley & Sons: New York, 2003; Vol. IV Chemotherapeutic Agents (Anticancer, Antibacterial, Antimicrobial and Antiviral).
14. Felici, A.; Amicosante, G.; Oratase, A.; Strom, R.; Ledent, P.; Joris, B.; Fanuel, L.; Frere, J.-M. An overview of the kinetic properties of class B β lactamases. Biochem. J. 1993, 291, 151-155 (Pubitemid 23107763)
15. Ledent, P.; Raquet, X.; Joris, B.; Van Beeumen, J.; Frere, J. M. A comparative study of class-D beta-lactamases Biochem. J. 1993, 292 (Pt 2), 555-62
16. Matagne, A.; Misselyn-Bauduin, A. M.; Joris, B.; Erpicum, T.; Granier, B.; Frere, J.-M. The diversity of catalytic properties of class A β-lactamases. Biochem. J. 1990, 265, 131-146 (Pubitemid 20037683)
17. Waley, S. G. β -Lactamase: mechanism of action. A. and P. Blackie: London, 1992.
18. Bennett, P. M.; Chopra, I. Molecular basis of β-lactamase induction in bacteria. Antimicrob. Agents Chemother. 1993, 37, 153-158 (Pubitemid 23046546)
19. Jack, G. W.; Richmond, M. H. A comparative study of eight distinctβ-lactamases synthesized by gram-negative bacteria. J. Gen. Microbiol. 1970, 61, 43-61
20. Richmond, M. H.; Sykes, R. B. The β-lactamases of Gram negative bacteria and their possible physiological role. Adv. Microb. Physiol. 1973, 9 31-88
21. Bush, K. Characterization of β -lactamases. Antimicrob. Agents Chemother. 1989, 33, 259-276
22. Bush, K.; Jacoby, G. A.; Medeiros, A. A. A functional classification scheme for β-lactamases and its correlation with molecular structures. Antimicrob. Agents Chemother. 1995, 39, 1211-1233
23. Hall, B. G.; Barlow, M. Revised Ambler classification of β -lactamases. J. Antimicrob. Chemother. 2005, 1050-1051
24. Ambler, R. P. The structure of β -lactamases. Philos Trans R. Soc. Lond. B Biol. Sci. 1980, 289, 321-31
25. Bush, K.; Jacoby, G. A., Updated functional classification of beta-lactamases Antimicrob. Agents Chemother. 2010, 54, 969-76
26. Strynadka, N. C.; Adachi, H.; Jensen, S. E.; Johns, K.; Sielecki, A.; Betzel, C.; Sutoh, K.; James, M. N. Molecular structure of the acyl-enzyme intermediate in β -lactam hydrolysis at 1.7 A resolution. Nature 1992, 359, 700-705
27. Meroueh, S. O.; J. F. Fisher, J. F.; Schlegel, H. B.; Mobashery, S., Ab initio QM/MM study of class A β -lactamase acylation: dual participation of Glu166 and Lys73 in a concerted base promotion of Ser70. .J. Am. Chem. Soc. 2005, 127, 15397-15407 (Pubitemid 41572513)
28. Shanshan, W.; Dingguo Xu; Guo, H. QM/MM Studies of Monozinc β- Lactamase CphA Suggest That the Crystal Structure of an Enzyme- Intermediate Complex Represents a Minor Pathway. J. Am. Chem. Soc. 2010, 132, 17986-17988
29. Garau, G.; Bebrone, C.; Anne, C.; Galleni, M.; Frere, J. M.; Dideberg, O. A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. J. Mol. Biol. 2005, 345, 785-795 (Pubitemid 39600934)
30. Simona, F.; Magistrato, A.; Dal Peraro, M.; Cavalli, A.; Vila, A. J.; Carloni, P. Common Mechanistic Features among Metallo-β-lactamases: A computational study of aeromonas hydrophila cpha enzyme J. Biol. Chem. 2009, 284, 28164-28171
31. Wommer, S.; Rival, S.; Heinz, U.; Galleni, M.; Frere, J. M.; Franceschini, N.; Amicosante, G.; Rasmussen, B.; Bauer, R.; Adolph, H. W. Substrateactivated zinc binding of metallo-beta-lactamases: physiological importance of mononuclear enzymes. J. Biol. Chem. 2002, 277, 24142-24147 (Pubitemid 34951928)
32. Sykes, R. B.; Matthew, M. The β-lactamases of Gram-negative bacteria and their role in resistance to β -lactam antibiotics. J. Antimicrob. Chemother. 1976, 2, 115-157 (Pubitemid 8094781)
33. Sykes, R. B.; Matthew, M. Detection, assay and immunology of β-lactamases. Academic Press, Ltd.: London., 1979
34. Matthew, M. Plasmid mediated β -lactamases of gram-negative bacteria: distribution and properties. J. Antimicrob. Chemother. 1979, 5, 349-358 (Pubitemid 9242441)
35. Tzouvelekis, L. S.; Tzelepi, E.; Tassios, P. T.; Legakis, J. CTX-Mtype betalactamases: an emerging group of extended spectrum enzymes. Int. J. Antimicrob. Agents 2000, 14, 137-142 (Pubitemid 30138181)
36. Jacoby, G. A. AmpC beta-lactamases Clin. Microbiol. Rev. 2009, 22, 161-82
37. Bradford, P. A.; Urban, C.; Mariano, N.; Projan, S. J.; Rahal, J. J.; Bush, K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob. Agents Chemother. 1997, 41, 563-9 (Pubitemid 27098404)
38. Naas, T.; Sougakoff, W.; Casetta, A.; Nordmann, P. Molecular characterization of OXA-20, a novel class D beta-lactamase, and its integron from Pseudomonas aeruginosa Antimicrob. Agents. Chemother. 1998, 42, 2074-83 (Pubitemid 28363096)
39. Daiyasu, H.; Osaka, K.; Ishino, Y.; Toh, H., Expansion of the zinc metallohydrolase family of the beta-lactamase fold FEBS Lett. 2001, 503, 1-6 (Pubitemid 32769945)
40. Rasmussen, B. A.; Gluzman, Y.; Tally, F. P. Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636. Antimicrob. Agents Chemother. 1990, 34, 1590-2 (Pubitemid 20257614)
41. Rossolini, G. M.; Franceschini, N.; Riccio, M. L.; P S Mercuri, P. S.; M Perilli, M.; M Galleni, M.; Frere, J. M.; Amicosante, G. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile. Biochem. J. 1998, 332, (Pt 1 ), 145-152 (Pubitemid 28239329)
42. Osano, E.; Arakawa, Y.; Wacharotayankun, R.; Ohta, M.; Horii, T.; Ito, H.; Yoshimura, F.; Kato, N. Molecular characterization of an enterobacterial metallo β -lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 1994, 38, 71-78 (Pubitemid 24018160)
43. Watanabe, M.; Iyobe, S.; Inoue, M.; Mitsuhashi, S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991, 35, 147-151
44. Chen, Y.; Succi, J.; Tenover, F. C.; Koehler, T. M. Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain. J. Bacteriol. 2003, 185, 823-830 (Pubitemid 36139441)
45. Yong, D.; Toleman, M. A.; Giske, C. G.; Cho, H. S.; Sundman, K.; Lee, K.; Walsh, T. R. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrob. Agents Chemother. 2009, 53, 5046-5054
46. Walsh, F.; Bracher, S., .; Turner, P.; Amyes, S. Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa Chemotherapy 2007, 53, 407-409 (Pubitemid 350085254)
47. Galleni, M.; Lamotte-Brasseur, J.; Rossolini, G. M.; Spencer, J.; Dideberg, O.; Frere, J. M., Standard numbering scheme for class B beta-lactamases Antimicrob. Agents Chemother. 2001, 45, 660-663. (Pubitemid 32182004)
48. Garau, G.; Garcia-Saez, I.; Bebrone, C.; Anne, C.; Mercuri, P.; Galleni, M.; Frère, G. M.; Dideberg, O. Update of the standard numbering scheme for class B beta-lactamases. Antimicrob. Agents Chemother. 2004, 48, 2347-2349 (Pubitemid 38823395)
49. Frere, J. M.; Galleni, M.; Bush, K.; Dideberg, O. Is it necessary to change the classification of β-lactamases? J. Antimicrob. Chemother. 2005, 55, 1051-1053
50. Bebrone, C.; Lassaux, P.; Vercheval, L.; Sohier, J. S.; Jehaes, A.; Sauvage, E.; Galleni, M. Current Challenges in Antimicrobial Chemotherapy: Focus on β-lactamase Inhibition. Drugs 2010, 70, 651-679
51. Cullmann, W.; Binder, S.; Stieglitz, M. Sulbactam and clavulanic acid: enzyme kinetics and synergy with ampicillin and mezlocillin. Intern. J. Antimicrob. Agents 1996, 6 Suppl., S1-S7 (Pubitemid 126657462)
52. Durkin, J. P.; Viswanatha, T. Clavulanic acid inhibition of beta-lactamase I from Bacillus cereus 569/H J. Antibiot. 1978, 31, 1162-9 (Pubitemid 9086609)
53. Reading, C.; Cole, M. Clavulanic acid: a beta-lactamase inhibiting betalactam from Streptomyces clavuligerus Antimicrob. Agents Chemother. 1977, 11, 852-7 (Pubitemid 8119260)
54. English, A. R.; Retsema, J. A.; Girard, A. E.; Lynch, J. E.; Barth, E. W. CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of β-Lactams: Initial Bacteriological Characterization. Antimicrob. Agents Chemother. 1978, 14, 414-419 (Pubitemid 9027812)
55. Jacobs, M. R.; Aronoff, S. C.; Johenning, S.; Shlaes, D. M.; Yamabe, S. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli. Antimicrob. Agents Chemother. 1986, 29, 980-985 (Pubitemid 16084058)
56. Appelbaum, P. C.; Jacobs, M. R.; Spangler, S. K.; Yamabe, S. Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes. Antimicrob. Agents Chemother. 1986, 30, 789-91 (Pubitemid 17187715)
57. Totir, M. A.; Cha, J.; Ishiwata, A., Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence. Biochemistry 2008, 47, 4094-101 (Pubitemid 351458123)
58. Bush, K.; Macalintal, C.; Rasmussen, B. A.; Lee, V. J.; Yang, Y. Kinetic interactions of tazobactam with beta-lactamases from all major structural classes. Antimicrob. Agents Chemother. 1993, 37, 851-858 (Pubitemid 23096890)
59. Bonomo, R.; Rudin, S.; Shlaes, D. Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamases. FEMS Microbiol. Lett. 1997, 148, 59-62 (Pubitemid 27128357)
60. Gutmann, L.; Ferré, B.; Goldstein, F. W.; Rizk, N.; Pinto-Schuster, E.; Acar, J. F.; Collatz, E. SHV-5, A novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob. Agents Chemother. 1989, 33, 951-956 (Pubitemid 19146590)
61. Doi, Y.; Wachino, J.-i.; Ishiguro, M.; Kurokawa, H.; Yamane, K.; Shibata, N.; Shibayama, K.; Yokoyama, K.; Kato, H.; Yagi, T.; Arakawa, Y. Inhibitor-Sensitive AmpC β-Lactamase Variant Produced by an Escherichia coli Clinical Isolate Resistant to Oxyiminocephalosporins and Cephamycins. Antimicrob. Agents Chemother. 2004, 48, 2652-2658 (Pubitemid 38823438)
62. Marshall, M. J.; Ross, G. W.; Chanter, K. V.; Harris, A. M. Comparison of the Substrate Specificities of the β-Lactamases from Klebsiella aerogenes 1082E and Enterobacter cloacae P99 Appl. Environ. Microbiol. 1972, 23, 765-769
63. Stachyra, T.; Péchereau, M.-C.; Bruneau, J.-M.; Claudon, M.; Frère, J.-M.; Miossec, C.; Coleman, K.; Black, M. T. Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non-β-Lactam β- Lactamase Inhibitor. Antimicrob. Agents Chemother. 2010, 54, 5132-5138
64. Bush, K.; Jacoby, G. A.; Medeiros, A. A. A Functional Classification Scheme for β -Lactamases and Its Correlation with Molecular Structure. Antimicrob. Agents Chemother. 1995, 39, 1211-1233
65. Brown, A. G.; Butlerworth, D.; Cole, M.; Hanscomb, G.; Hood, J. D.; Reading, C.; Rolinson, G. N. Naturally-occurring betalactamase inhibitors with antibacterial activity. J. Antibiot. 1976, 29, 668-669
66. Brown, A. G.; Corbett, D. F.; Goodacre, J.; Harbridge, J. B.; Howarth, T. T.; Ponsford, R. J.; Stirling, I.; King, T. I. Clavulanic acid and its derivatives. Structure elucidation of clavulanic acid and the preparation of dihydroclavulanic acid, isoclavulanic acid, esters and related oxidation products J. Chem. Soc., Perkin Trans. 1: 1984, 635-650
67. Cierpucha, M.; Panfil, I.; Danh Tong, T.; Chmielewski, M.; Kurzatkowski, W.; Rajnisz, A.; Solecka, J. Synthesis of 3-Substituted-clavams: Antifungal Properties, DD-Peptidase and beta-Lactamase Inhibition. J. Antibiot. 2007, 60, 622-632
68. Knight, G. C.; Waley, S. G. Inhibition of class C beta-lactamases by (10R,6R)-6-(10-hydroxy)benzylpenicillanic acid SS-dioxide. Biochem. J. 1985, 225, 435-9 (Pubitemid 15162189)
69. Jones, R. N.; Johnson, D. M. Comparative in vitro activity of apalcillin alone and combined with Ro 48-1220, a novel penam beta-lactamase inhibitor. Clin. Microbiol. Infect. 1995, 1, 86-100
70. Richter, H. G. F.; Angehrn, P.; Hubschwerlen, C.; Kania, M.; Page, M. G. P.; Specklin, J. L.; Winkler, F. K. Design, synthesis, and evaluation of 2 betaalkenyl penam sulfone acids as inhibitors of beta-lactamases. J. Med. Chem. 1996, 39, 3712-3722 (Pubitemid 26307877)
71. Bitha, P.; Li, Z.; Francisco, G. D.; Yang, Y.; Petersen, P. J.; Lenoy, E.; Lin, Y.-I. 6-(1-Hydroxyalkyl) penam sulfone derivatives as inhibitors of class A and class C beta-lactamases II Bioorg. Med. Chem. Lett. 1999, 9, 991-996 (Pubitemid 29179895)
72. Tzouvelekis, L. S.; Gazouli, M.; Prinarakis, E. E.; Tzelepi, E.; Legakis, N. J. Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be. Antimicrob. Agents Chemother. 1997, 41, 475-477 (Pubitemid 27111051)
73. Buynak, J. D.; Ghadachanda, V. R.; Vogeti, L.; Zhang, H.; Chen, H. Synthesis and Evaluation of 3-(Carboxymethylidene)- and 3- (Carboxymethyl) penicillinates as Inhibitors of OEβ-Lactamase. J. Org. Chem. 2005, 70, 4510-4513 (Pubitemid 40734169)
74. Buynak, J. D.; Rao, A. S.; Doppalapudi, V. R.; Adam, G.; Petersen, J. P.; Nidamarthy, D. S. The synthesis and evaluation of 6-alkylidene- 2′betasubstituted penam sulfones as beta-lactamase inhibitors Bioorg. Med. Chem. Lett. 1999, 9, 1997-2002. (Pubitemid 29336389)
75. Buynak, J. D.; Chen, H.; Vogeti, L.; Gadhachandaa, V. R.; Buchananb, C. A.; Palzkillc, T.; Shawd, R. W.; Spencere, J.; Walsh, T. R. Penicillin-derived inhibitors that simultaneously target both metallo- and serine-betalactamases. Bioorg. Med. Chem. Lett. 2004, 14, 1299-1304 (Pubitemid 38229875)
76. Beharry, Z.; Chen, H.; Gadhachanda, V. R.; Buynak, J. D.; Palzkill, T. Evaluation of penicillin-based inhibitors of the class A and B betalactamases from Bacillus anthracis. Biochem. Biophys. Res. Commun. 2004, 313, 541-545 (Pubitemid 38021862)
77. Crichlow, G. V.; Nukaga, M.; Doppalapudi, V. R.; Buynak, J. D.; Knox, J. R. Inhibition of class C beta-lactamases: structure of a reaction intermediate with a cephem sulfone. Biochemistry 2001, 40, 6233-6239 (Pubitemid 32472711)
78. Buynak, J. D.; Doppaiapudi, V. R.; Chambers, A. Catalytic approaches to the synthesis of beta-lactamase inhibitors. Tetrahedron 2000, 56, 5709
79. Buynak, J. D.; Doppalapudi, V. R.; Adam, G. The synthesis and evaluation of 3-substituted-7-(alkylidene)cephalosporin sulfones as beta-lactamase inhibitors Bioorg. Med. Chem. Lett. 2000, 10, 853-857 (Pubitemid 30301580)
80. Padayatti, P. S.; Sheri, A.; Totir, M. A.; Helfand, M. S.; Carey, M. P.; Anderson, V. E.; Carey, P. R.; Bethel, C. R.; Bonomo, R. A.; Buynak, J. D.; van den Akker, F., Rational Design of a Beta-Lactamase Inhibitor Achieved via Stabilization of the trans-Enamine Intermediate: Crystal Structure of wt SHV-1 Complex with a Penam Sulfone. J. Am. Chem. Soc. 2006, 128, 13235-13242 (Pubitemid 44527694)
81. Helfand, M. S.; Taracila, M. A.; Totir, M. A.; Bonomo, R. A.; Buynak, J. D.; van den Akker, F.; Carey, P. R. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors. Biochemistry 2007, 46, (29), 8689-8699 (Pubitemid 47106119)
82. Pattanaik, P.; Bethel, C. R.; Hujer, A. M.; Hujer, K. M.; Distler, A. M.; Taracila, M. T.; Anderson, V. E.; Fritsche, T. R.; Jones, R. N.; Pagadala, S. R. R.; van den Akker, F.; Buynak, J. D. Strategic design of an effective betalactamase inhibitor: LN-1-255, a 6-alkylidene-2′-substituted penicillin sulfone. J. Biol. Chem. 2009, 284, 945-953
83. Drawz, S. M.; Bethel, C. R.; Doppalapudi, V. R.; Sheri, A.; Pagadala, S. R. R.; Hujer, A. M.; Skalweit, M. J.; Anderson, V. E.; Chen, S. G.; Buynak, J. D.; Bonomo, R. A. Penicillin Sulfone Inhibitors of Class D β- Lactamases{triangledown. Antimicrob. Agents Chemother. 2010, 54, 1414-24
84. Bou, G.; Santillana, E.; Sheri, A.; Beceiro, A.; Sampson, J. M.; Kalp, M.; Bethel, C. R.; Distler, A. M.; Drawz, S. M.; Pagadala, S. R. R.; van den Akker, F.; Bonomo, R. A.; Romero, A.; Buynak, J. D. Design, Synthesis, and Crystal Structures of 6-Alkylidene-2′-Substituted Penicillanic Acid Sulfones as Potent Inhibitors of Acinetobacter baumannii OXA-24 Carbapenemase. J. Am. Chem. Soc. 2010, 132, 13320-13331
85. Buynak, J. D.; Sheri, A.; Pagadala, S. R. R. Preparation and antibacterial activity of beta-lactamase inhibitory compounds. US 2010009954 A1 20100114, 2010
86. Senthilkumar Udayampalayam, P.; Andrew, G.; Panchapakesan, G.; Mukut, G.; Venkatasubramanian, H.; Sriram, R.; Maneesh, P.-S.; Shakti, S. S.; Sathishkumar, D. Novel 2-substituted methyl penam derivatives. 20080015156, 2008
87. Nottingham, M.; Bethel, C. R.; Pagadala, S. R. R.; Harry, E.; Pinto, A.; Lemons, Z. A.; Drawz, S. M.; Akker, F. V. D.; Carey, P. R.; Bonomo, R. A.; Buynak, J. D. Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy. Bioorg. Med. Chem. Lett. 2011, 21, 387-393
88. Coleman, K.; Griffin, D. R.; J.W., P.; Upshon, P. A. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob. Agents Chemother. 1989, 33, 1580-1587 (Pubitemid 19228018)
89. Mansour, T., S.; Venkatesan, A., M.; Bradford, P.; Petersen, P., J.; Projan, S. J. Bicyclic 6-alkylidene-penem β?lactamase inhibitors and beta-lactam antibiotic combination: a broad spectrum antibiotic. WO/2007/016134, 2007
90. Petersen, P. J.; Jones, C. H.; Venkatesan, A. M.; Bradford, P. A. Efficacy of piperacillin combined with the penem beta-lactamase inhibitor BLI-489 in murine models of systemic infection. Antimicrob. Agents Chemother. 2009, 53, 1698-700
91. Petersen, P. J.; Jones, C. H.; Venkatesan, A. M.; Mansour, T., S.; Projan, S. J.; Bradford, P. A. Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem beta-lactamase inhibitor BLI-489. Antimicrob. Agents Chemother. 2009, 53, 370-384
92. Bush, K.; Macielag, M. J. New b-lactam antibiotics and b-lactamase inhibitors. Expert Opin. Ther. Patents 2010, 20, (10), 1277-1293.
93. Papp-Wallace, K. M.; Bethel, C. R.; Distler, A. M.; Kasuboski, C.; Taracila, M.; Bonomo, R. A. Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A βLactamase Antimicrob. Agents Chemother. 2010, 54, 890-897
94. Endimiani, A.; Bethel, C. R.; Choudhary, Y.; Bonomo, R. A. In vitro Activity of Penem-1 in Combination with β-Lactams against blaKPCPossessing Klebsiella pneumoniae Isolates Antimicrob. Agents Chemother. 2010, 54, 1650-1651
95. Bethel, C. R.; Distler, A. M.; Ruszczycky, M. W.; Carey, M. P.; Carey, P. R.; Hujer, A. M.; Taracila, M.; Helfand, M. S.; Thomson, J. M.; Kalp, M.; Anderson, V. E.; Leonard, D. A.; Hujer, K. M.; Abe, T.; Venkatesan, A. M.; Mansour, T. S.; Bonomo, R. A. Inhibition of OXA-1 beta-lactamase by penems. Antimicrob. Agents Chemother. 2008, 52, 3135-3143
96. Ganta, S. R.; Perumal, S.; Pagadala, S. R. R.; Samuelsen, Y.; Spencer, J.; Pratt, R. F.; Buynak, J. D. Approaches to the simultaneous inactivation of metallo- and serine-[beta]-lactamases. Bioorg. Med. Chem. Lett. 2009, 19,1618-1622
97. Simpson, I.; Pfaendler, H., Rudolf, H. Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics. WO/2002/074287, 2002
98. Jamieson, C. E.; Lambert, P. A.; Simpson, I. N. In vitro and in vivo activities of AM-112, a novel oxapenem. Antimicrob. Agents Chemother. 2003, 47, 1652-7 (Pubitemid 36548551)
99. Jamieson C.E.; Lambert P.A. In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gramnegative organisms. Antimicrob. Agents Chemother. 2003, 47, (8), 2616-2618
100. Biondi, S.; Pecunioso, A.; Busi, F.; Contini, S. A.; Donati, D.; Maffeis, M.; Pizzi, D. A.; Rossi, L.; Rossi, T.; Sabbatini, F. M. Highly diastereoselective synthesis of 4-N-methylformamidino trinem (GV129606), a potent antibacterial agent. Tetrahedron 2000, 56, 5649-5655 (Pubitemid 30619314)
101. Guercio, G.; Perboni, A.; Tinazzi, F.; Rovatti, L.; Provera, S. The Synthesis of GV143253A: A Case Study for the Use of Analytical and Statistical Tools to Elucidate the Reaction Mechanism and to Optimize the Process. Org. Process Res. Dev. 2010, 14, 840-848
102. Sader, H. S.; Gales, A. C. Emerging strategies in infectious diseases - New carbapenem and trinem antibacterial agents. Drugs 2001, 61, 553-564 (Pubitemid 32453367)
103. Paukner, S.; Hesse, L.; Prezelj, A.; Solmajer, T.; Urleb, U. In vitro activity of LK-157, a novel tricyclic carbapenem as broad-spectrum beta-lactamase inhibitor. Antimicrob. Agents Chemother. 2009, 53, 505-11
104. Prezelj, A.; Urleb, U. S.; Vilfan, G. S. Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics. WO/2009/095387, 2009
105. Plantan, I.; Selic, L.; Mesar, T.; Stefanic Anderluh, P.; Oblak, M.; Prezelj, A.; Hesse, L.; Andrejasic, M.; Vilar, M.; Turk, D.; Kocijan, A.; Prevec, T.; Vilfan, G.; Kocjan, D.; Copar, A.; Urleb, U.; Solmajer, T. 4-Substituted Trinems as Broad Spectrum β -Lactamase Inhibitors: Structure-Based Design, Synthesis, and Biological Activity. J. Med. Chem. 2007, 50, 4113-4121 (Pubitemid 47301743)
106. Iglicar, P.; Legen, I.; Vilfan, G.; Selic, L.; Prezelj, A. Permeability of a novel beta-lactamase inhibitor LK-157 and its ester prodrugs across rat jejunum in vitro. .J. Pharm. Pharmacol. 2009, 61, 1211-1218
107. Livermore, D. M.; Chen, H. Y., Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamases. J. Antimicrob. Chemother. 1997, 40, 335-343 (Pubitemid 27437951)
108. Heinze-Krauss, I.; Angehrn, P.; Charnas, R. L.; Gubernator, K.; Gutknecht, E.-M.; Hubschwerlen, C.; Kania, M.; Oefner, C.; Page, M. G. P.; Satoshi Sogabe; Specklin, J.-L.; Winkler, F., Structure based design of betalactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams. J. Med. Chem. 1998, 41, 3961-3971 (Pubitemid 28483473)
109. Netzel, T. C.; Jindani, I.; Hanson, N.; Turner, B. M.; Smith, L.; Rand, K. H. The AmpC inhibitor, Syn2190, can be used to reveal extended-spectrum beta-lactamases in Escherichia coli. Diagn. Microbiol. Infect. Dis. 2007, 58, 345-348 (Pubitemid 47017639)
110. Nishida, K.; Kunugita, C.; Uji, T.; Higashitani, F.; Hyodo, A.; Unemi, N.; Maiti, S. N.; Phillips, O. A.; Spevak, P.; Atchison, K. P.; Salama, S. M.; Atwal, H.; Micetich, R. G. In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor. Antimicrob. Agents Chemother. 1999, 43, 1895-1900 (Pubitemid 29395182)
111. Blizzard, T., A. ; Chen, H., Y. ; Wu, J., Yang ; Kim, S.; Ha, S.; Mortko, C., J.; Variankaval, N.; Chiu, A. Novel inhibitors of beta-lactamase. WO/2008/039420, 2008
112. Blizzard, T., A.; Chen, H.; Gude, C.; Hermes, J., D.; Imbriglio, J., E.; Kim, S.; Wu, J., Y.; Ha, S.; Mortko, C., J.; Mangion, I.; Rivera, N.; Ruck, R., T.; Shevlin, M. beta-Lactamase inhibitors. WO/2009/091856, 2009
113. Blizzard, T. A.; Chen, H.; Kim, S.; Wu, J.; Young, K.; Park, Y.-W.; Ogawa, A.; Raghoobar, S.; Painter, R. E.; Hairston, N.; Lee, S. H.; Misura, A.; Felcetto, T.; Fitzgerald, P.; Sharma, N.; Lu, J.; Ha, S.; Hickey, E.; Hermes, J.; Hammond, M. L. Side chain SAR of bicyclic [beta]-lactamase inhibitors (BLIs). 1. Discovery of a class C BLI for combination with imipinem. Bioorg. Med. Chem. Lett. 2010, 20, 918-921
114. Livermore, D. M.; Mushtaq, S.; Warner, M. Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms. J. Antimicrob. Chemother. 2010, 65, 2382-2395
115. Livermore, D. M.; Mushtaq, S.; Warner M; Miossec, C.; Woodford, N. NXL104 combinations versus Enterobacteriaceae with CTX-M extendedspectrum beta-lactamases and carbapenemases. J. Antimicrob. Chemother. 2008, 62, 1053-56
116. Lampilas, M.; Rowlands, D., Alun; Kebsi, A.; Ledoussal, B.; Pierres, C. Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments. WO/2008/142285, 2008.
117. Mushtaq, S.; Warner, M.; Williams, G.; Critchley I.; Livermore, D. M. Activity of chequerboard combinations of ceftaroline and NXL104 versus β- lactamase-producing Enterobacteriaceae J. Antimicrob. Chemother. 2010, 65, 1428-1432
118. Bremner, J. B.; Ambrus, J. I.; Samosorn, S., Dual action-based approaches to antibacterial agents. Curr. Med. Chem. 2007, 14, 1459-1477 (Pubitemid 46902226)
119. Panunzio, M.; Malabarba, A.; Vicennati, P., Synthesis and antibacterial activity of new antibiotics arising from cephalosporin-monobactam coupling. Arkivoc. 2004, (Part 13), 36-47 (Pubitemid 39337062)